New Delhi: Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to turn out to be India’s fifth-largest pharmaceutical firm (up from seventh), capturing a 4.6% share (up from 3.6%) of the Rs 2.3 lakh crore organised retail market. Significantly, the deal propels Torrent to turn out to be the primary participant within the over Rs 30,000 crore cardiac remedy market (transferring annual whole or 12-month interval ended May 25), overtaking the chief Sun Pharma, from an current 7% to practically 11% share (MAT May 25). Sun Pharma leads the extremely fragmented market with gross sales of simply over Rs 19,000 crore and an 8.3% share (MAT May 25). The Ahmedabad-based agency, flagship of the Torrent group, follows Cipla, which has a 5.2% market share. The Torrent scrip closed practically 2% greater at Rs 3410, whereas the discounted open provide worth noticed JB Chem’s inventory worth plunging by over 6% to Rs 1680 on the BSE on Monday.